CAS No. |
127785-64-2 |
中文名称 |
(3S,6S,9S,12S,15R,18S,21S,24S,29aS)-21,24-二苄基-3,15-二((R)-仲丁基)-12-(2-羟基丙-2-基)-9-异丁基-6,18-二异丙基-5,11,17,23-四甲基十八氢-1H,15H-吡咯并[1,2-m][1]氧杂[4,7,10,13,16,19,22,25]八氮杂环二十七烷-1,4,7,10,13,16,19,22,25-九酮 |
英文名称 |
(3S,6S,9S,12S,15R,18S,21S,24S,29aS)-21,24-Dibenzyl-3,15-di((R)-sec-butyl)-12-(2-hydroxypropan-2-yl)-9-isobutyl-6,18-diisopropyl-5,11,17,23-tetramethyloctadecahydro-1H,15H-pyrrolo[1,2-m][1]oxa[4,7,10,13,16,19,22,25]octaazacycloheptacosine-1,4,7,10,13,16,19,22,25-nonaone |
别名 |
Cyclo[L-Phe-N-methyl-L-Phe-L-Pro-L-aIle-N-methyl-L-Val-L-Leu-N-methyl-β-hydroxy-L-Val-[(3R)-D-Hmp-]-N-methyl-L-Val-];LY-295337;Aureobasidin A (9CI);Aureobasidin A (AbA);Basifungin;aureobasidin A;Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N,3-dimethyl-L-threonyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];Basifungin/Aureobasidin A |
标准英文名 |
(3S,6S,9S,12S,15R,18S,21S,24S,29aS)-21,24-dibenzyl-3,15-di((R)-sec-butyl)-12-(2-hydroxypropan-2-yl)-9-isobutyl-6,18-diisopropyl-5,11,17,23-tetramethyloctadecahydro-1H,15H-pyrrolo[1,2-m][1]oxa[4,7,10,13,16,19,22,25]octaazacycloheptacosine-1,4,7,10,13,16,19,22,25-nonaone |
MDL No. |
MFCD01675341 |
分子式 |
C60H92N8O11 |
分子量 |
1101.44
|
精确分子量 |
1100.69
|
SMILES |
CC[C@@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H]([C@H](C)CC)OC(=O)[C@H](C(C)(C)O)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C1=O |
标准SMILES |
CC(C)C[C@@H]1NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2C=CC=CC=2)N(C)C(=O)[C@H](CC2C=CC=CC=2)NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](OC(=O)[C@@H](N(C)C1=O)C(C)(C)O)[C@H](C)CC)[C@H](C)CC |
用途 |
Aureobasidin A is a cyclic depsipeptide antifungal antibiotic with potent activity against various fungi, including Saccharomyces cerevisiae, Schizosaccharomyces pombe, Candida glabrata, Aspergillus nidulans, and Aspergillus niger, exhibiting toxicity to yeast at low concentrations (0.1–0.5 μg/mL); it inhibits inositol phosphorylceramide (IPC) synthase, thereby disrupting sphingolipid biosynthesis essential for fungal growth, without affecting DNA, RNA, or protein synthesis; polyethylene glycol (PEG)-modified aureobasidin A exhibits enhanced solubility, prolonged half-life due to steric hindrance reducing enzymatic degradation in vivo, decreased renal clearance, and improved therapeutic efficacy; PEGylated aureobasidin A can be formulated into antifungal pharmaceuticals. |
InChIKey |
RLMLFADXHJLPSQ-QKCBWMAHSA-N |